BR9907936A - Composição farmacêutica, composto, e, processo para preparar o mesmo - Google Patents
Composição farmacêutica, composto, e, processo para preparar o mesmoInfo
- Publication number
- BR9907936A BR9907936A BR9907936-4A BR9907936A BR9907936A BR 9907936 A BR9907936 A BR 9907936A BR 9907936 A BR9907936 A BR 9907936A BR 9907936 A BR9907936 A BR 9907936A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- preparing
- same
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Abstract
"COMPOSIçãO FARMACêUTICA, COMPOSTO OU UM SAL, éSTER OU AMIDA DESTE, E, PROCESSO PARA PREPARAR O MESMO". Uma composição farmacêutica que compreende um composto da fórmula (I) ou um sal ou ésteres de amidas deste farmaceuticamente aceitáveis, que é um inibidor da proteína-1 quimioatraente de monócito e em que A e B juntos formam um anel aromático de 5 membros opcionalmente substituído que inclui pelo menos um heteroátomo; X é CH~ 2~ ou SO~ 2~; R¹ é um anel de arila ou de heteroarila opcionalmente substituído; R² é selecionado de uma faixa de grupos orgânicos que incluem carboxi e R³ é hidrogênio, ou uma faixa de grupos orgânicos; em combinação com um veículo farmaceuticamente aceitável. Certos compostos da fórmula (I) são novos e estes formam um outro aspecto da invenção.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9803228.7A GB9803228D0 (en) | 1998-02-17 | 1998-02-17 | Chemical compounds |
PCT/GB1999/000335 WO1999040914A1 (en) | 1998-02-17 | 1999-02-02 | Bicyclic pyrrole derivatives as mcp-1 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9907936A true BR9907936A (pt) | 2000-10-24 |
Family
ID=10827056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9907936-4A BR9907936A (pt) | 1998-02-17 | 1999-02-02 | Composição farmacêutica, composto, e, processo para preparar o mesmo |
Country Status (16)
Country | Link |
---|---|
US (1) | US6479527B1 (pt) |
EP (1) | EP1056451B1 (pt) |
JP (1) | JP2002502874A (pt) |
KR (1) | KR20010040997A (pt) |
CN (1) | CN1291094A (pt) |
AT (1) | ATE227570T1 (pt) |
AU (1) | AU2432999A (pt) |
BR (1) | BR9907936A (pt) |
CA (1) | CA2319082A1 (pt) |
DE (1) | DE69903923T2 (pt) |
GB (1) | GB9803228D0 (pt) |
IL (1) | IL137876A0 (pt) |
NO (1) | NO20004091L (pt) |
NZ (1) | NZ505638A (pt) |
WO (1) | WO1999040914A1 (pt) |
ZA (1) | ZA99940B (pt) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9716657D0 (en) * | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
GB9902461D0 (en) | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB0000626D0 (en) * | 2000-01-13 | 2000-03-01 | Zeneca Ltd | Chemical compounds |
EP1307461A2 (en) * | 2000-08-04 | 2003-05-07 | Eli Lilly And Company | Substituted pyrrole compounds and their use as spla2 inhibitors |
CA2432369A1 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
AR035720A1 (es) | 2000-12-20 | 2004-07-07 | Bristol Myers Squibb Pharma Co | Derivados de amida ,composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de quimioquinas |
BR0207952A (pt) | 2001-03-07 | 2004-07-27 | Pfizer Prod Inc | Moduladores da atividade de receptores de quimiocina |
US6730694B1 (en) | 2001-07-20 | 2004-05-04 | Eli Lilly And Company | sPLA2 inhibitors |
US20050004180A1 (en) * | 2001-10-03 | 2005-01-06 | ZOU Dong | Pyrrolidinone derivatives |
WO2004022537A2 (en) | 2002-09-06 | 2004-03-18 | Janssen Pharmaceutica, N.V. | Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
US7338975B2 (en) | 2003-02-12 | 2008-03-04 | Bristol-Myers Squibb Co. | Lactams as modulators of chemokine receptor activity |
TW200508224A (en) | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
US7230133B2 (en) | 2003-05-01 | 2007-06-12 | Bristol-Myers Squibb Company | Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
US7291615B2 (en) | 2003-05-01 | 2007-11-06 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
SE0302035D0 (sv) * | 2003-07-09 | 2003-07-09 | Biolipox Ab | New compound |
US7163937B2 (en) * | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
RU2361862C2 (ru) * | 2003-12-29 | 2009-07-20 | Сепракор Инк. | Пиррольные и пиразольные ингибиторы daao |
US7230022B2 (en) | 2004-02-19 | 2007-06-12 | Bristol-Myers Squibb Company | Substituted fused bicyclic amines as modulators of chemokine receptor activity |
US7288563B2 (en) | 2004-02-19 | 2007-10-30 | Bristol-Myers Squibb Company | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
US7479496B2 (en) | 2004-02-19 | 2009-01-20 | Bristol-Myers Squibb Company | Substituted spiro azabicyclics as modulators of chemokine receptor activity |
US7381738B2 (en) | 2004-02-19 | 2008-06-03 | Bristol-Myers Squibb Company | Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
US8481035B2 (en) | 2004-04-27 | 2013-07-09 | Northwestern University | Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A |
BRPI0512253A (pt) * | 2004-06-18 | 2008-02-19 | Biolipox Ab | composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto |
CA2570365A1 (en) * | 2004-06-18 | 2005-12-29 | Biolipox Ab | Indoles useful in the treatment of inflammation |
CN101006053A (zh) | 2004-06-18 | 2007-07-25 | 比奥里波克斯公司 | 用于治疗炎症的吲哚 |
JP2008514700A (ja) * | 2004-09-28 | 2008-05-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 置換されたジピペリジンccr2アンタゴニスト |
CA2594726C (en) * | 2005-01-14 | 2013-03-19 | Chemocentryx, Inc. | Heteroaryl sulfonamides and ccr2 |
US7622583B2 (en) * | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
ATE501119T1 (de) | 2005-01-19 | 2011-03-15 | Biolipox Ab | Entzündungshemmende indol-derivate |
JP2008527031A (ja) * | 2005-01-19 | 2008-07-24 | バイオリポックス エービー | 炎症の治療に有用なピロロピリジン誘導体 |
EP1844051A1 (en) * | 2005-01-19 | 2007-10-17 | Biolipox AB | Thienopyrroles useful in the treatment of inflammation |
US20100197687A1 (en) * | 2005-01-19 | 2010-08-05 | Benjamin Pelcman | Indoles Useful in the Treatment of Inflammation |
EP1844013A1 (en) * | 2005-01-19 | 2007-10-17 | Biolipox AB | Indoles useful in the treatment of inflammation |
CA2594773A1 (en) * | 2005-01-19 | 2006-07-27 | Biolipox Ab | Indoles useful in the treatment of inflammation |
JP2009500425A (ja) | 2005-07-06 | 2009-01-08 | セプラコア インコーポレーテッド | エスゾピクロン及びトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−n−メチル−1−ナフタレンアミン又はトランス4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロ−1−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法 |
EP1978961B1 (en) | 2006-01-06 | 2016-03-16 | Sunovion Pharmaceuticals Inc. | Tetralone-based monoamine reuptake inhibitors |
CA2636324C (en) | 2006-01-06 | 2012-03-20 | Sepracor Inc. | Cycloalkylamines as monoamine reuptake inhibitors |
PT2013835E (pt) | 2006-03-31 | 2016-01-06 | Sunovion Pharmaceuticals Inc | Preparação de amidas and aminas quirais |
US7579370B2 (en) * | 2006-06-30 | 2009-08-25 | Sepracor Inc. | Fused heterocycles |
CA2659060A1 (en) * | 2006-06-30 | 2008-01-10 | Sepracor Inc. | Fused heterocyclic inhibitors of d-amino acid oxidase |
US20080058395A1 (en) * | 2006-06-30 | 2008-03-06 | Sepracor Inc. | Fused heterocyclic inhibitors of D-amino acid oxidase |
US7884124B2 (en) | 2006-06-30 | 2011-02-08 | Sepracor Inc. | Fluoro-substituted inhibitors of D-amino acid oxidase |
US8519135B2 (en) * | 2006-07-14 | 2013-08-27 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2/CCR9 |
US7629351B2 (en) | 2006-07-28 | 2009-12-08 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process |
US7687508B2 (en) | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
US7671062B2 (en) | 2006-07-28 | 2010-03-02 | Bristol-Myers Squibb Company | Modulators of chemokine receptor activity, crystalline forms and process |
JP5306818B2 (ja) | 2006-10-18 | 2013-10-02 | 武田薬品工業株式会社 | 縮合複素環化合物 |
MX2009007410A (es) * | 2007-01-18 | 2009-09-09 | Sepracor Inc | Inhibidores de d-aminoacido oxidasa. |
US7902252B2 (en) | 2007-01-18 | 2011-03-08 | Sepracor, Inc. | Inhibitors of D-amino acid oxidase |
JP5420534B2 (ja) | 2007-05-31 | 2014-02-19 | サノビオン ファーマシューティカルズ インク | モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン |
KR101849560B1 (ko) * | 2007-07-12 | 2018-04-17 | 케모센트릭스, 인크. | 염증의 치료를 위한 ccr2 조절물질로서 융합된 헤테로아릴 피리딜과 페닐 벤젠술폰아마이드 |
WO2010017418A1 (en) * | 2008-08-07 | 2010-02-11 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
CA2733247C (en) * | 2008-08-14 | 2018-04-03 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
US20110034434A1 (en) * | 2009-08-07 | 2011-02-10 | Sepracor Inc. | Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
RU2765737C2 (ru) | 2016-11-23 | 2022-02-02 | Хемоцентрикс, Инк. | Способ лечения фокально-сегментарного гломерулосклероза |
WO2018106931A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
WO2018112264A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
US10758540B2 (en) | 2017-10-11 | 2020-09-01 | Chemocentryx, Inc. | Treatment of focal segmental glomerulosclerosis with CCR2 antagonists |
WO2020106757A1 (en) | 2018-11-19 | 2020-05-28 | Progenity, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
EP3870261B1 (en) | 2019-12-13 | 2024-01-31 | Biora Therapeutics, Inc. | Ingestible device for delivery of therapeutic agent to the gastrointestinal tract |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2537974A1 (fr) * | 1982-12-16 | 1984-06-22 | Adir | Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
FR2565981B1 (fr) * | 1984-06-15 | 1986-09-19 | Adir | Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant |
US4751231A (en) | 1987-09-16 | 1988-06-14 | Merck & Co., Inc. | Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents |
AU4514496A (en) * | 1994-12-13 | 1996-07-03 | Smithkline Beecham Corporation | Novel compounds |
TR199701096T1 (xx) | 1995-04-04 | 1998-02-21 | Texas Biotechnology Corporation | Tienil-, Furil-, Pirolil- ve Bifenils�lfonamidler ve Bunlar�n Endotelin Etkinli�ini D�zenleyen T�revleri. |
AU6966696A (en) * | 1995-10-05 | 1997-04-28 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
JP2000516611A (ja) * | 1996-08-14 | 2000-12-12 | ワーナー―ランバート・コンパニー | Mcp―1アンタゴニストとしての2―フェニルベンズイミダゾール誘導体 |
-
1998
- 1998-02-17 GB GBGB9803228.7A patent/GB9803228D0/en not_active Ceased
-
1999
- 1999-02-02 WO PCT/GB1999/000335 patent/WO1999040914A1/en not_active Application Discontinuation
- 1999-02-02 CA CA002319082A patent/CA2319082A1/en not_active Abandoned
- 1999-02-02 CN CN99803003A patent/CN1291094A/zh active Pending
- 1999-02-02 AU AU24329/99A patent/AU2432999A/en not_active Abandoned
- 1999-02-02 JP JP2000531166A patent/JP2002502874A/ja active Pending
- 1999-02-02 IL IL13787699A patent/IL137876A0/xx unknown
- 1999-02-02 DE DE69903923T patent/DE69903923T2/de not_active Expired - Fee Related
- 1999-02-02 EP EP99903810A patent/EP1056451B1/en not_active Expired - Lifetime
- 1999-02-02 KR KR1020007009018A patent/KR20010040997A/ko not_active Application Discontinuation
- 1999-02-02 AT AT99903810T patent/ATE227570T1/de not_active IP Right Cessation
- 1999-02-02 NZ NZ505638A patent/NZ505638A/xx not_active Application Discontinuation
- 1999-02-02 BR BR9907936-4A patent/BR9907936A/pt not_active IP Right Cessation
- 1999-02-05 ZA ZA9900940A patent/ZA99940B/xx unknown
-
2000
- 2000-07-26 US US09/626,378 patent/US6479527B1/en not_active Expired - Fee Related
- 2000-08-16 NO NO20004091A patent/NO20004091L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB9803228D0 (en) | 1998-04-08 |
AU2432999A (en) | 1999-08-30 |
IL137876A0 (en) | 2001-10-31 |
EP1056451A1 (en) | 2000-12-06 |
US6479527B1 (en) | 2002-11-12 |
NO20004091D0 (no) | 2000-08-16 |
EP1056451B1 (en) | 2002-11-13 |
CN1291094A (zh) | 2001-04-11 |
NO20004091L (no) | 2000-10-16 |
NZ505638A (en) | 2002-09-27 |
DE69903923T2 (de) | 2003-07-10 |
ATE227570T1 (de) | 2002-11-15 |
CA2319082A1 (en) | 1999-08-19 |
WO1999040914A1 (en) | 1999-08-19 |
JP2002502874A (ja) | 2002-01-29 |
KR20010040997A (ko) | 2001-05-15 |
ZA99940B (en) | 1999-08-17 |
DE69903923D1 (de) | 2002-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9907936A (pt) | Composição farmacêutica, composto, e, processo para preparar o mesmo | |
BR9907962A (pt) | Composição farmacêntica, composto, e, processo para preparar o mesmo | |
IS6309A (is) | Kínasólínafleiður | |
BR0008015A (pt) | Uso de um composto, composto, composições farmacêuticas, e, processo para preparar um composto | |
RU95108387A (ru) | Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина | |
TW200510441A (en) | Novel compounds | |
NO2009001I1 (no) | Rivaroksaban | |
BR0206738A (pt) | Derivados tricìclicos de lactama e de sultama e uso dos mesmos como inibidores de histona desacetilase | |
EA199800141A1 (ru) | Гетероциклические соединения | |
DE69920888D1 (de) | Disubstituierte pyrazoline und triazoline als faktor xa inhibitoren | |
ES2189968T3 (es) | Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS. | |
DE69732571D1 (de) | Beta-sulfonyl-hydroxamsäuren als matrix-metalloproteinaseinhibitoren | |
AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
IT1295933B1 (it) | 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione | |
FI935799A0 (fi) | Arylsubstituerade heterocykliska foereningar | |
DK0604355T3 (da) | Arylsubstituerede heterocykliske forbindelser | |
DE60308204D1 (de) | Verfahren zur herstellung von aminopyrrolidinderivaten | |
PE20030758A1 (es) | 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion | |
GT200200077A (es) | Derivados de cromano 2,6-sustituidos utiles como agonistas adrenorreceptores beta-3 | |
MX9604347A (es) | Derivados del acido 2-(4-pirazoliloxi-pirimidin-5-il) acetico. | |
GT199500052A (es) | Derivados de acido hidroxamico con sustitucion triciclica. | |
TH52208A (th) | อนุพันธ์ของ n-เฟนิแลมีด และ n-พิริดิแลมีด ต่าง ๆ ชนิดใหม่ วิธีการของการเตรียมอนุพันธ์เหล่านี้ และสารผสมเชิงเภสัชกรรมที่มีอนุพันธ์เหล่านี้อยู่ด้วย | |
TH22954A (th) | อนุพันธ์เฮเทอโรไซคลิค สไปโร |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTA A 5O, 6O, 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |